Michael P N Findlay

7PUBLICATIONS
35CO-AUTHORS
Nutritional epidemiologyTesting, assessment and psychometricsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2025
A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity.

Nuala Helsby, Katrina Sharples, Yu Jin Kim

|Jun 05, 2025
The younger women's wellness after cancer program: results from feasibility testing in Aotearoa New Zealand (the 'Kōwhai study').

Janine P Porter-Steele, Katrina J Sharples, Bobbi B Laing

|Sep 27, 2021
Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?

Soo Hee Jeong, Ottiniel Chavani, Kathryn Burns

|Jun 11, 2021
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Nuala Helsby, Minghan Yong, Kathryn Burns

|Mar 09, 2021
Comparison of a thymine challenge test and endogenous uracil-dihydrouracil levels for assessment of fluoropyrimidine toxicity risk.

Kathryn E Burns, Ottiniel Chavani, Soo Hee Jeong

|Apr 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.

Jonathan S Cebon, Martin Gore, John F Thompson

Pageof 2

Frequent Collaborators

5 joint publications

Kathryn E Burns

5 joint publications

David Porter

5 joint publications

Nuala Helsby

3 joint publications

Soo Hee Jeong